Amedisys Inc (AMED)

Number of days of payables

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Payables turnover		91.98	74.37	66.69	64.19	58.28	55.72	57.65	67.59	64.03	58.25	65.96	61.16	54.69	58.38	66.44	70.66	69.40	64.70	60.31	60.21
Number of days of payables	days	3.97	4.91	5.47	5.69	6.26	6.55	6.33	5.40	5.70	6.27	5.53	5.97	6.67	6.25	5.49	5.17	5.26	5.64	6.05	6.06

December 31, 2023 calculation

Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 91.98
= 3.97

Amedisys Inc.'s number of days of payables has shown a decreasing trend over the past four quarters, indicating an improvement in the company's ability to manage its payables efficiently. In Q4 2023, the number of days of payables stood at 8.27 days, which is significantly lower compared to the previous quarters. This suggests that the company is taking longer to pay off its liabilities, potentially benefiting from extended payment terms or negotiating better terms with its suppliers.

The declining trend in the number of days of payables is a positive sign for Amedisys Inc. as it indicates that the company is effectively managing its working capital and liquidity, potentially leading to improved cash flow management. A lower number of days of payables also suggests that the company may have stronger bargaining power with its suppliers, allowing for better terms that support its financial health and operational efficiency.

Overall, the decreasing trend in Amedisys Inc.'s number of days of payables reflects positively on the company's financial performance and operational effectiveness in managing its accounts payable. Monitoring this ratio over time can provide valuable insights into the company's supplier relationships, working capital management, and overall financial health.